Entries tagged "Food and Drug Administration"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Food and Drug Administration."

12 result(s) displayed (1 - 12 of 21)

Unigene gets financing ahead of auction

The troubled maker of peptide-based drugs raises $750,000 to help it get operating and will hold an auction on April 15 of some of its assets, including a drug delivery platform. Continue reading

Posted on April 9, 2013 12:12 PM

Allergan pays steep premium for migraine specialist

The drugmaker will acquire MAP Pharmaceuticals in deal that values the target's equity at $958 million, giving analysts who follow the buyer an aching head. Continue reading

Posted on January 23, 2013 4:20 PM

Teva aims to unloose more dollars for restructuring

The Israeli drug giant's CEO tells attendees at the JPMorgan Healthcare Conference that the company is surveying all nonlabor expenditures to find efficiencies that would yield cash it would use on fewer therapeutic areas. Continue reading

Posted on January 10, 2013 2:21 PM

Obesity drugmaker raises more venture funding

Alta Partners, Atlas Venture and Third Rock Ventures provide a $21 million Series D equity financing to Zafgen, which has just initated Phase 2a trials for its promising therapy called beloranib. Continue reading

Posted on December 6, 2012 2:47 PM

Acquisition gives Merit to cardiology products

The $167 million deal will give the maker of disposable medical devices used in interventional and diagnostic procedures a portfolio of catheter-based vascular access delivery devices. Continue reading

Posted on November 27, 2012 2:33 PM

Idenix slapped with second FDA hold

The ripple effects of Bristol-Myers' Inhibitex problems continue Continue reading

Posted on August 27, 2012 2:26 PM

Sarepta shares surge on drug breakthrough

After the company releases positive Phase 2b data on eteplirsen, a compound that treats Duchenne muscular dystrophy, talk turns to the possibility of a takeover Continue reading

Posted on July 25, 2012 9:22 AM

Otologics looks to sell assets

Cochlear offers $14 million for the rival hearing aid maker and provides a $1.645 million postpetition loan Continue reading

Posted on July 24, 2012 3:20 PM

Bleeding cash, K-V sues FDA

The pharmaceutical company says pressures over its list price are keeping its pregnancy drug from selling more. Continue reading

Posted on July 12, 2012 10:18 AM

Forest fires back at Icahn

The pharmaceutical company files a broadside ahead of an Aug. 15 meeting Continue reading

Posted on July 10, 2012 4:00 AM

EC quashes Allos drug payout

The decision tied to the approval of Folotyn cannot be appealed, but rejection does not endanger the company's $200 million merger with Spectrum Pharmaceuticals. Continue reading

Posted on June 28, 2012 4:19 PM

Laster issues cross-country bench slap

In disregarding a federal judge's ruling, the Delaware vice chancellor launches another battle cry for where plaintiffs should sue Continue reading

Posted on June 20, 2012 6:00 AM

Movable Type search results powered by Fast Search